InsiderFlow

Christopher Yea

KALV

Christopher Yea serves as officer: CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

29 trades

$2.56M

Net Position

Net Seller

$2.56M

Companies Traded

1

KALV

Active Period

May 2021 – Feb 2026

29 total trades

Most Recent

Sell KALV

Feb 24, 2026 · $135.3K

Christopher Yea's Insider Trading at KalVista Pharmaceuticals, Inc. (KALV)

Buys

0 · $0.00

Sells

29 · $2.56M

Total Shares Bought

0

Total Shares Sold

183,986

KALV Price Chart
Loading chart...
DateTypeValue
Feb 24, 2026 Sell$135.3K
Feb 17, 2026 Sell$16.6K
Nov 26, 2025 Sell$58.3K
Nov 19, 2025 Sell$38.8K
Aug 26, 2025 Sell$26.2K
Aug 25, 2025 Sell$31.2K
Aug 19, 2025 Sell$34.9K
Jul 10, 2025 Sell$474.7K
May 27, 2025 Sell$21.8K
May 23, 2025 Sell$27.5K
May 20, 2025 Sell$30.8K
Feb 25, 2025 Sell$19.2K
Feb 19, 2025 Sell$25.6K
Nov 27, 2024 Sell$19.4K
Nov 19, 2024 Sell$66.6K
Aug 26, 2024 Sell$23.8K
Aug 21, 2024 Sell$85.3K
May 21, 2024 Sell$136.6K
Feb 21, 2024 Sell$170.1K
Feb 16, 2024 Sell$598.7K
Nov 21, 2023 Sell$58.5K
Aug 21, 2023 Sell$76.6K
May 19, 2023 Sell$26.4K
Feb 23, 2023 Sell$20.9K
Nov 21, 2022 Sell$6.2K
Aug 19, 2022 Sell$17.1K
Nov 3, 2021 Sell$90.3K
Aug 4, 2021 Sell$102.6K
May 6, 2021 Sell$124.2K
Christopher Yea Insider Trading Activity | KalVista Pharmaceuticals, Inc. | InsiderFlow